How May Cannabis Legalization Affect the Adverse Health Effects of Cannabis?
Abstract
Abstract: This paper briefly reviews the effects to date of the US model of cannabis legalization – a for profit model based on that of alcohol. The US model has substantially reduced the cost of cannabis, increased its availability and potency, and increased the prevalence of regular use among adult users. The paper makes some predictions about the likely impacts of adopting this model in other nations that are contemplating the legalization of adult cannabis use.
Zusammenfassung: Dieser Beitrag gibt einen kurzen Überblick über die bisherigen Auswirkungen des US-amerikanischen Modells der Cannabislegalisierung – ein gewinnorientiertes Modell, das sich an dem des Alkohols orientiert. Das US-Modell hat die Kosten für Cannabis erheblich gesenkt, seine Verfügbarkeit und Stärke erhöht und die Prävalenz des regelmäßigen Konsums unter erwachsenen Konsumenten gesteigert. Das Papier enthält einige Vorhersagen über die wahrscheinlichen Auswirkungen der Übernahme dieses Modells in anderen Ländern, die die Legalisierung des Cannabiskonsums für Erwachsene in Erwägung ziehen.
References
(2017). Recognizing and regulating cannabis as a temptation good. International Journal of Drug Policy, 42, 50–56.
(2018). Big data on a big new market: insights from Washington State’s legal cannabis market. International Journal of Drug Policy, 57, 86–94.
(2020). Estimation of the proportion of population cannabis consumption in Australia that is accounted for by daily users using Monte Carlo Simulation. Addiction, 115, 1182–1186.
(2021). Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA. Neuropharmacology, 193, 108610.
(2021). Cannabis use and cannabis use disorder. Nature Reviews Disease Primers, 7, 16.
(2021). Cannabis Legalisation – Canada’s Experience. A research report by Public First. https://www.publicfirst.co.uk/wp-content/uploads/2021/10/REPORT-Cannabis-in-Canada-Public-First-October-2021.pdf
(2020). The effects of cannabis use on the development of adolescents and young adults. Annual Review of Developmental Psychology, 2, 461–483.
(2020). Assessing the public health impacts of legalizing recreational cannabis use: the US experience. World Psychiatry, 19, 179–186.
(2016). The health and social effects of nonmedical cannabis use. World Health Organization. https://www.who.int/publications/i/item/9789241510240
(2019). Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Lancet, 394, 1580–1590.
(2021). Trends over time in adult cannabis use: a review of recent findings. Current Opinion in Psychology, 38, 80–85.
(2015). Risks associated with the non-medicinal use of cannabis. Deutsches Ärzteblatt International, 112, 271–278.
(2020). What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis. Addictive Behaviors, 109, 106479.
(2021). Trends in cannabis involvement and risk of alcohol involvement in motor vehicle crash fatalities in the United States, 2000–2018. American Journal of Public Health, 111, 1976–1985.
(2022). Federal regulations of cannabis for public health in the United States (Schaeffer Center White Paper Series). Leonard D Schaeffer Center for Health Policy & Economics. https://healthpolicy.usc.edu/research/federal-regulations-of-cannabis-for-public-health-in-the-u-s/
(2022). Association of cannabis potency with mental ill health and addiction: a systematic review. Lancet Psychiatry, 9, 736–750.
(2019). Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: findings from state policy evaluations. American Journal of Drug and Alcohol Abuse, 45, 644–663.
